Real-world evidence for ixekizumab in the treatment of psoriasis and psoriatic arthritis: literature review 2016–2021-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Real-world evidence for ixekizumab in the treatment of psoriasis and psoriatic arthritis: literature review 2016–2021

Published:2023-01-20 Issue:1 Volume:34 Page:
ISSN:0954-6634
Container-title:Journal of Dermatological Treatment
language:en
Short-container-title:Journal of Dermatological Treatment

Author:

Reich Adam¹,Reed Catherine²,Schuster Christopher³,Robert Camille⁴,Treuer Tamas⁵,Lubrano Ennio⁶

Affiliation:

1. Department of Dermatology, University of Rzeszów, Rzeszów, Poland

2. Eli Lilly and Company Limited, Bracknell, UK

3. Eli Lilly and Company, Vienna, Austria

4. Lilly France, Neuilly Sur Seine, France

5. Lilly Hungária Kft, Budapest, Hungary

6. Internal Medicine and Rheumatology Unit, University of Molise, Campobasso, Italy

Funder

Eli Lilly and Company

Publisher

Informa UK Limited

Subject

Dermatology

Link

https://www.tandfonline.com/doi/pdf/10.1080/09546634.2022.2160196

Reference91 articles.

2. Diagnosis and management of psoriasis;Kim WB;Can Fam Physician,2017

3. Psoriasis prevalence among the 2009 AAD National Melanoma/Skin Cancer Screening Program participants

4. Global Epidemiology of Psoriasis: A Systematic Review of Incidence and Prevalence

5. US Perspectives in the Management of Psoriasis and Psoriatic Arthritis: Patient and Physician Results from the Population-Based Multinational Assessment of Psoriasis and Psoriatic Arthritis (MAPP) Survey

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment-emergent Candida infections in patients with psoriasis, psoriatic arthritis, and axial spondyloarthritis treated with ixekizumab: an integrated safety analysis of 25 clinical studies;Expert Opinion on Drug Safety;2024-09-12

2. Retention Rate of Ixekizumab in Psoriatic Arthritis: A Real-World Study;Journal of Personalized Medicine;2024-07-03

3. Certolizumab Pegol for the Treatment of Plaque Psoriasis in Routine Clinical Practice: One-Year Results from the CIMREAL Study;Dermatology and Therapy;2024-06-27

4. Ixekizumab Demonstrates Rapid and Consistent Efficacy for Patients with Psoriatic Arthritis, Regardless of Psoriasis Severity;Dermatology and Therapy;2024-05-30

5. Real‐World Treatment Patterns, Clinical Outcomes, and Symptom Burden in Patients With Psoriatic Arthritis Prescribed Ixekizumab in the United States;ACR Open Rheumatology;2024-05-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3